Methyl 4-methoxypiperidine-4-carboxylate hydrochloride, 98%, 5g

Amsacrine hydrochloride, 98%, 5g

(2s)-1-(9h-carbazol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol, 98%, 10mg

3-Morpholinobenzaldehyde, 95.0%, 5g

1-Butyl-1H-benzo[d][1,2,3]triazole, 95.0%, 250mg

4-Bromo-5-chloro-2-fluoroiodobenzene, 5g

(2-((Phenylamino)methyl)phenyl)boronic acid, 95.0%, 5g

4,5,6,7-Tetrahydrobenzo[b]thiophene-2-carboxamide, 97%, 100mg

1-[1-(1-pyrrolidinylmethyl)cyclopropyl]methanamine dihydrochloride, 95.0%, 10g

5-Chloro-1,3-thiazol-2-amine hydrochloride, 97.0%, 250mg

5-Chloromethyl-3-(4-nitro-phenyl)-[1,2,4]oxadiazole, 97.0%, 10g

Colonna capillare per GC ROTI®Cap-1, 25 m, 0,32 mm, 0,35 µm, 1 Pezzo(i)

2-Chloro-4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 98%, 250mg